Reducing Nicotine in Cigarettes: Is It Time to Enable/Nudge/Push Smokers to Move Away from the Most Deadly Tobacco Products?

About this Seminar

Nicotine is the primary constituent in cigarettes driving the acquisition and maintenance of smoking behavior. The Biden Administration recently announced its intention to pursue a low nicotine product standard for cigarettes and other combusted tobacco products, reviving a pillar of the Comprehensive Framework for Nicotine and Tobacco Regulation announced in 2017. A similar approach is moving forward in New Zealand. Dr. Donny's seminar will review the science underlying nicotine reduction and discuss ways to optimize the likelihood that mandating very low nicotine levels in smoked tobacco will achieve the intended public health outcomes.

Additional Details

This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Addiction Recovery Research Center and the Center for Health Behaviors Research. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.

You May Also Be Interested In...